tiprankstipranks
Trending News
More News >
Kane Biotech Inc (TSE:KNE)
:KNE
Canadian Market

Kane Biotech (KNE) Financial Statements

Compare
1 Followers

Kane Biotech Financial Overview

Kane Biotech's market cap is currently C$9.12M. The company's EPS TTM is C$; its P/E ratio is ―; Kane Biotech is scheduled to report earnings on May 29, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueC$ 2.08MC$ 148.98KC$ 2.67MC$ 1.61MC$ 1.34M
Gross ProfitC$ 653.63KC$ 109.47KC$ 1.41MC$ 568.44KC$ 526.86K
Operating IncomeC$ -4.49MC$ -3.36MC$ -3.36MC$ -4.88MC$ -4.22M
EBITDAC$ -3.71MC$ -3.23MC$ -2.95MC$ -4.25MC$ -3.65M
Net IncomeC$ -3.02MC$ -5.03MC$ -3.89MC$ -4.60MC$ -3.72M
Balance Sheet
Cash & Short-Term InvestmentsC$ 358.81KC$ 749.25KC$ 1.10MC$ 1.15MC$ 1.01M
Total AssetsC$ 2.49MC$ 5.68MC$ 5.62MC$ 6.13MC$ 5.04M
Total DebtC$ 2.18MC$ 9.26MC$ 6.86MC$ 4.71MC$ 2.25M
Net DebtC$ 1.82MC$ 8.51MC$ 5.75MC$ 3.56MC$ 1.24M
Total LiabilitiesC$ 4.12MC$ 14.09MC$ 9.76MC$ 7.70MC$ 3.96M
Stockholders' EquityC$ -1.63MC$ -10.56MC$ -6.52MC$ -3.89MC$ -1.49M
Cash Flow
Free Cash FlowC$ -4.14MC$ -3.23MC$ -3.13MC$ -2.64MC$ -4.07M
Operating Cash FlowC$ -4.11MC$ -3.22MC$ -3.04MC$ -2.29MC$ -3.94M
Investing Cash FlowC$ 10.27MC$ -116.14KC$ -107.55KC$ -373.55KC$ -166.11K
Financing Cash FlowC$ -7.69MC$ 2.98MC$ 3.10MC$ 2.81MC$ 4.28M
Currency in CAD

Kane Biotech Earnings and Revenue History

Kane Biotech Debt to Assets

Kane Biotech Cash Flow

Kane Biotech Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis